Clinical trial
Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung…
NCT00084981 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00084981 |
|---|---|
| Title | Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer |
| Official title | A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Non-Small Cell Lung Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer |
| Intervention type | Drug, Other |
| Interventions | decitabine, valproic acid, pharmacological study, laboratory biomarker analysis |
| Enrollment | 25 |
| Start date | Apr 1, 2004 |
| Primary completion | Feb 1, 2013 |
| First posted | Jun 11, 2004 |
| Last update posted | Sep 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: